This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Improving Cardiovascular Treatment Approaches Among Minorities

This study has been completed.
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
University of Maryland
ClinicalTrials.gov Identifier:
NCT00101478
First received: January 10, 2005
Last updated: March 28, 2017
Last verified: March 2017
  Purpose
The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities. Specifically, the study will aim to improve provider and patient approaches to treatment of hypertension and diabetes, respectively.

Condition
Cardiovascular Diseases Heart Diseases Diabetes Mellitus Hypertension

Study Type: Observational
Study Design: Observational Model: Case-Control
Time Perspective: Other
Official Title: Partnership Programs to Reduce Cardiovascular Disparities - Baltimore Partnership

Further study details as provided by University of Maryland:

Enrollment: 823
Actual Study Start Date: September 2004
Study Completion Date: January 2011
Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
The study groups will be selected from primary and family health clinics, community, and patients of physicians participating in the study.
Criteria

Inclusion Criteria:

  • Uncontrolled hypertension or diabetes

Exclusion Criteria:

  • Medical condition that would prevent treatment for hypertension at the University of Maryland
  • Medical condition that would prevent treatment for diabetes at Bon Secours
  • Uninsured
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00101478

Locations
United States, Maryland
University of Maryland Baltimore
Baltimore, Maryland, United States, 21201
Bon Secours Hospital
Baltimore, Maryland, United States, 21223
Sponsors and Collaborators
University of Maryland
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Elijah Saunders, MD University of Maryland
Principal Investigator: Reed Winston, MD Bon Secours Hospital Baltimore
Principal Investigator: Fadia T. Shaya, PhD, MPH Universitiy of Maryland Baltimore
Principal Investigator: Wallace R. Johnson, MD Bon Secours Hospital Baltimore
  More Information

Responsible Party: University of Maryland
ClinicalTrials.gov Identifier: NCT00101478     History of Changes
Other Study ID Numbers: HP-00040555
U01HL079151 ( U.S. NIH Grant/Contract )
Study First Received: January 10, 2005
Last Updated: March 28, 2017

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on August 23, 2017